• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease.

作者信息

Axelsson C, Jarnum S

出版信息

Scand J Gastroenterol. 1977;12(1):89-95.

PMID:834975
Abstract

Thirty-four patients with chronic inflammatory bowel disease, 23 with ulcerative colitis, and 11 with crohn's disease, weretreated with elemental diet. thirty-one patients had been on high dose prednisonetherapy one to four weeks prior to the diet with no or insufficient response. Fifteen patients (44%) went into remission when elemental diet was introduced as the only change of treatment. Furthermore six patients (18%) went into remission when the dietary treatment was supplemented with high dose prednisone treatment (2 cases) or an increase of prednisone dose (4 cases). Remission occurred in 16 of 21 patients with disease of moderate activity, but in only 5 of 13 cases with severe disease. Remission rate was higher in patients with a limited extent of the lesion, but 8 patients with extensive colitis responded to treatment. There was no significant change of haemoglobin serum iron, transferrin, albumin, orosomucoid, or renal excretion of creatinine. However, significant decreases were observed of sedimentation rate, renal urea excretion, faecal volume and daily number of bowel movements. Colectomy was performed in 8 patients whose condition remained unchanged or aggravated during treatment. Follow-up studies of non-operated patients who went into remission showed that 6 of 13 patients with ulcerative colitis were perfectly well 7-28 months after the study, 3 patients suffered a mild recurrence after 4-24 months, and 4 patients were colectomized 5-10 months later due to severe attack. Of 8 patients with Crohn's disease 4 remained unoperated and free of symptoms 22-35 months after the study.

摘要

相似文献

1
Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease.
Scand J Gastroenterol. 1977;12(1):89-95.
2
6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.接受硫唑嘌呤治疗的炎症性肠病类固醇依赖患者的6-硫鸟嘌呤监测
Aliment Pharmacol Ther. 2005 Apr 1;21(7):829-39. doi: 10.1111/j.1365-2036.2005.02419.x.
3
Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.静脉注射免疫球蛋白治疗活动性、广泛性及药物难治性特发性溃疡性或克罗恩氏结肠炎。
Am J Gastroenterol. 1992 Jan;87(1):91-100.
4
[Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].[环孢素A治疗对类固醇难治性慢性炎症性肠病患者的疗效]
Wien Klin Wochenschr. 1998 Sep 4;110(16):579-84.
5
High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease.高剂量静脉注射环孢素治疗炎症性肠病的类固醇难治性发作
Hepatogastroenterology. 1999 Jul-Aug;46(28):2265-8.
6
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.他克莫司对重度激素难治性或激素依赖性炎症性肠病患者安全有效——一项长期随访研究
Am J Gastroenterol. 2006 May;101(5):1048-56. doi: 10.1111/j.1572-0241.2006.00524.x.
7
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.普通肝素在高活性炎症性肠病患者治疗中的应用
Am J Gastroenterol. 1999 Jun;94(6):1551-5. doi: 10.1111/j.1572-0241.1999.01143.x.
8
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).炎症性肠病的类固醇无反应性急性发作:他克莫司(FK506)的免疫调节作用
Am J Gastroenterol. 1998 Oct;93(10):1860-6. doi: 10.1111/j.1572-0241.1998.539_g.x.
9
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.加拿大一所三级护理大学医院中炎症性肠病患者的直接住院费用。
Am J Gastroenterol. 2000 Mar;95(3):677-83. doi: 10.1111/j.1572-0241.2000.01845.x.
10
The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.白细胞计数可预测硫唑嘌呤治疗炎症性肠病的疗效。
Eur J Med Res. 2005 Dec 7;10(12):535-8.

引用本文的文献

1
Meta-Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis.荟萃分析:成年溃疡性结肠炎患者的全肠内营养
Aliment Pharmacol Ther. 2025 Mar;61(5):756-775. doi: 10.1111/apt.18495. Epub 2025 Jan 16.
2
Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders.以机械转导过程为靶点进行胃肠道疾病的治疗干预。
Front Pharmacol. 2021 Dec 21;12:809350. doi: 10.3389/fphar.2021.809350. eCollection 2021.
3
Elemental diets role in treatment of high ileostomy output and other gastrointestinal disorders.
要素饮食在治疗高回肠造口输出量及其他胃肠道疾病中的作用。
Gastroenterol Hepatol Bed Bench. 2015 Winter;8(1):71-6.
4
Role of diet in the management of inflammatory bowel disease.饮食在炎症性肠病管理中的作用。
World J Gastroenterol. 2010 Mar 28;16(12):1442-8. doi: 10.3748/wjg.v16.i12.1442.
5
Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical.炎症性肠病中炎症反应的营养调节——从分子层面到整合层面再到临床层面
World J Gastroenterol. 2007 Jan 7;13(1):1-7. doi: 10.3748/wjg.v13.i1.1.
6
Therapy of Crohn's disease in childhood.儿童克罗恩病的治疗
Paediatr Drugs. 2000 May-Jun;2(3):193-203. doi: 10.2165/00128072-200002030-00004.
7
[What is the role of nutrition in ulcerative colitis?].
Langenbecks Arch Chir. 1995;380(1):1-3. doi: 10.1007/BF00184409.
8
Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel.要素饮食减少小肠克罗恩病患者胃肠道蛋白质丢失
Gut. 1981 May;22(5):383-7. doi: 10.1136/gut.22.5.383.
9
Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stable-isotope tracer with chenodeoxycholic-11, 12-d2 acid.口服稳定同位素示踪剂鹅去氧胆酸 -11, 12 - d2酸后,克罗恩病患者在要素饮食情况下的胆汁酸吸收动力学。
Gut. 1982 Sep;23(9):751-7. doi: 10.1136/gut.23.9.751.
10
Elemental diet in acute Crohn's disease.急性克罗恩病中的要素饮食
Arch Dis Child. 1983 Jan;58(1):44-7. doi: 10.1136/adc.58.1.44.